Price Chart

Executive Summary

Guardant Health filed a universal shelf registration statement (S-3ASR) on July 30, 2026, allowing the company and selling stockholders to offer and sell up to an indeterminate amount of common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, and units from time to time. No specific offering size, pricing, or terms were disclosed — registration fees are deferred under Rule 457(r). This is a routine capital markets filing that provides financial flexibility but does not represent an immediate dilutive event.

Key Facts

• Filed universal shelf registration (S-3ASR) on July 30, 2026 as a well-known seasoned issuer
• Covers common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, and units
• No specific offering size, price, or terms disclosed; registration fees deferred under Rule 457(r)
• Also covers potential resale of common stock by selling stockholders
• Form of indenture filed with U.S. Bank Trust Company, National Association as trustee for future debt securities
• Company has $19.1B market cap and 4 offering/registration filings in the last 24 months

Financial Impact

No immediate financial impact; future offerings could result in dilution or increased leverage depending on terms and size

Risk Factors

• Potential future dilution from equity or convertible offerings
• Potential increase in leverage from debt offerings
• Uncertainty about timing and terms of future takedowns

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

US Market Status